Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
J.P.Morgan Healthcare Conference #1: Investors Move Into Life Science Stocks-Bouncing Off The Bottom
Article By:
Rod Raynovich
Tuesday, January 12, 2016 8:28 PM EDT
We have a long way to recover in this bear market. The IBB touched near 52 week lows yesterday at $287 and is currently at $296 after a failed bounce then a recovery. We are down about 12% over five days.
Rayno Molecular Diagnostics And Tools Update: CPHD, HOLX, PACB
Article By:
Rod Raynovich
Wednesday, December 2, 2015 6:31 PM EDT
Lackluster revenue growth has tempered stock gains since Q3 earnings reports however the sector has always had good investment potential due to M&A and new products. Stocks are up from October lows.
Rayno Tools And Molecular Diagnostics: Looking For Value
Article By:
Rod Raynovich
Thursday, November 5, 2015 7:30 PM EDT
Life Science stocks took a big hit over the past summer and many have not fully recovered. The important metric to watch is sales growth because many of the smaller cap companies are still lagging in earnings growth so the PE tells you very little.
Slower Growth In Diagnostics Stocks Except For NexGen Sequencing And Molecular
Article By:
Rod Raynovich
Thursday, June 11, 2015 8:30 PM EDT
New technologies in diagnostics and tools are driving growth: NexGen sequencing, molecular and “point-of-care” testing platforms and veterinary testing. The sector is a laggard due to slowing sales and earnings growth.
In this article: ABAX, ALR, HOLX, ILMN, SQNM, TMO, EXAS, FMI, VRML, IWO Also: AXDX, GNMK, NVTA, HTGM